|

Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry

RECRUITINGN/ASponsored by Helse Fonna
Actively Recruiting
PhaseN/A
SponsorHelse Fonna
Started2026-03-01
Est. completion2027-06-01
Eligibility
Age12 Years – 18 Years
Healthy vol.Accepted

Summary

Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening/night use of blue-blocking glasses/real darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.

Eligibility

Age: 12 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 12-18 years, receiving health-care from child and adolescent mental health services at UPA University Hospital of North Norway, Tromsø or BUP Haugesund Hospital, Haugesund
* Current Insomnia or DSPD comorbid to one or several pychiatric symptom presentations or diagnoses
* Able and willing to provide written informed consent
* Participants aged 12-15,9 years also need consent from both parents/carers
* Able to comply with protocol
* Able to discontinue melatonin or BB-glasses if currently used, with at least 3 days washout period

Exclusion Criteria:

* Not able to comply with protocol for a required minimum of one night
* Blindness or severely reduced translucency of both eyes
* Known malformation or damage of optical tract blindness
* Use of melatonin all formulas that cannot be paused
* High risk for suicide or self-harm
* Consent from both partents/carers unlikely (participants age 12-15,9 years)

Conditions6

Child and Adolescent PsychiatryDelayed Sleep Phase DisorderHeart DiseaseHyperarousalInsomniaTransdiagnostic Psychopathology

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.